ARCHIVES

BioMedicines Begins Kidney Cancer Study; EntreMed Moves Forward.

This article is from The Cancer Letter archive.

Vol. 26 No. 08 | February 25, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

March 16, 2007

Other DCT Concepts Approved By Board

February 26, 1988

In Brief: Richard Fisher Named Fox Chase President and CEO

August 2, 2013

RFOs Available, Contract Awards, Sole Source Negotiations

February 3, 1978

Changes In Cooperative Groups As Result Of Move To DCT Topic Of Chairmen’s Meeting Sept. 16

August 22, 1975

New Breast Cancer Therapies Move Into General Practice; Fisher, Miami Plan Segmental Trials

February 13, 1976